A case series of 72 neonates with renal vein thrombosis

Summary

Neonatal renal vein thrombosis (RVT) is a well-recognized clinical entity which is associated with serious morbidity. However, current information regarding RVT has been restricted to case reports and small case series. In this study, it was our objective to describe patient demographics, clinical presentation, location and risk factors of RVT. For our study design, we looked at a case series of 72 neonates with RVT referred to the 1-800-NO-CLOTS consultation service between 9/1996 and 8/2001. Data on age, gender, associated conditions, prothrombotic disorders, family history, location of the thrombosis, diagnostic techniques, and treatment were prospectively recorded using a standardized form. Our results show that RVT affected males (65%, CI 52-76%) significantly more often than females (35%, CI 24-48%). Median age at presentation was 2 days (0-21 days). RVT was unilateral in 72% (left side: 67%, CI 49-81%; right side: 33%, CI 19-51%), and bilateral in 28%. The majority (83%) had at least one associated condition: Prematurity (54%), central venous lines (17%), a diabetic mother (13%), asphyxia (6%), infections (6%). Prothrombotic testing was performed in 21 neonates. Activated protein C resistance was found in 8 children (38%), other defects in three. This is the largest case series of neonatal RVT to date. Data from the study show that i) male infants are affected twice as often as females and ii) there appears to be a left-sided predominance of neonatal RVT. Neonatal RVT is only infrequently associated with the presence of a catheter as compared to thrombosis at other sites. The majority of infants have associated conditions with prematurity being most frequent. A small subset of neonates were screened for prothrombotic abnormalities and 50% of the children screened were positive.

Keywords

Clinical/epidemiological studies - neonates - thrombosis

• References

• 1 Schmidt B, Andrew M. Neonatal thrombosis: Report of a prospective canadian and international registry. Pediatrics 1995; 96: 939-43.
• 2 Nowak-Gottl U, von Kries R, Gobel U. Neonatal symptomatic thromboembolism in germany: Two year survey. Arch Dis Child Fetal Neonatal Ed 1997; 76: F163-7.
• 3 Andrew M, Brooker LA. Hemostatic complications in renal disorders of the young. Pediatr Nephrol 1996; 10: 88-99.
• 4 Mocan H, Beattie TJ, Murphy AV. Renal venous thrombosis in infancy: Long-term follow-up. Pediatr Nephrol 1991; 05: 45-9.
• 5 Keidan I, Lotan D, Gazit G. et al. Early neonatal renal venous thrombosis: Long-term outcome. Acta Paediatr 1994; 83: 1225-7.
• 6 Nuss R, Hays T, Manco-Johnson M. Efficacy and safety of heparin anticoagulation for neonatal renal vein thrombosis. Am J Pediatr Hematol Oncol 1994; 16: 127-31.
• 7 Bokenkamp A, von Kries R, Nowak-Gottl U. et al. Neonatal renal venous thrombosis in germany between 1992 and 1994: Epidemiology, treatment and outcome. Eur J Pediatr 2000; 159: 44-8.
• 8 Zigman A, Yazbeck S, Emil S. et al. Renal vein thrombosis: A 10-year review. J Pediatr Surg 2000; 35: 1540-2.
• 9 Andrew M. Society for pediatric research presidential address 1998: The SPR and 1-800-No-Clots: A common vision. Pediatr Res 1998; 44: 964-73.
• 10 Andrew M, David M, Adams M. et al. Venous thromboembolic complications (VTE) in children: First analyses of the Canadian registry of VTE. Blood 1994; 83: 1251-7.
• 11 Andrew M, Paes B, Milner R. et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165-72.
• 12 Andrew M, Paes B, Milner R. et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72: 1651-7.
• 13 Andrew M, Monagle P, Brooker L. Thromboembolic complications during infancy and childhood. Hamilton; BC Decker: 2000
• 14 Ricci MA, Lloyd DA. Renal venous thrombosis in infants and children. Arch Surg 1990; 125: 1195-9.
• 15 Orazi C, Fariello G, Malena S. et al. Renal vein thrombosis and adrenal hemorrhage in the newborn: Ultrasound evaluation of 4 cases. J Clin Ultrasound 1993; 21: 163-9.